NCT02419287 2023-03-06
Pilot Study of Crizotinib in Relapsed ALK+ Lymphomas
University of Milano Bicocca
Phase 2 Completed
Clinical Trials
3 trialsNCT02435108 2017-02-17
A Pilot Study of Crizotinib in Patients With c-MET Positive Gastric Adenocarcinoma as a Third-line Chemotherapy
Samsung Medical Center
Phase 2 Completed
NCT02487316 2016-12-30
A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib
Peking University
Phase 4 Withdrawn